References
- Bukhari SN, Jantan I, Unsal Tan O, et al. (2014). Biological activity and molecular docking studies of curcumin-related α,β-unsaturated carbonyl-based synthetic compounds as anticancer agents and mushroom tyrosinase inhibitors. J Agric Food Chem 62:5538–47
- Chinese Pharmacopoeia Committee. (2015). Pharmacopoeia of The People's Republic of China. Vol. 1. Beijing, China: China Medical Science Press, 360–1
- Gach K, Grądzka I, Wasyk I, et al. (2016). Anticancer activity and radiosensitization effect of methyleneisoxazolidin-5-ones in hepatocellular carcinoma HepG2 cells. Chem Biol Interact 248:68–73
- Han H, Qiu L, Wang X, et al. (2011). Physalins A and B inhibit androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression. Biol Pharm Bull 34:1584–8
- He H, Zang LH, Feng YS, et al. (2013a). Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-κB survival pathway in A375-S2 cells. J Ethnopharmacol 148:544–55
- He H, Zang LH, Feng YS, et al. (2013b). Physalin A induces apoptotic cell death and protective autophagy in HT1080 human fibrosarcoma cells. J Nat Prod 76:880–8
- He H, Feng YS, Zhang LH, et al. (2014). Nitric oxide induces apoptosis and autophagy; autophagy down-regulates NO synthesis in physalin A-treated A375-S2 human melanoma cells. Food Chem Toxicol 71:128–35
- He X, Li J, Gao H, et al. (2003). Identification of a rare sulfonic acid metabolite of Andrographolide in rats. Drug Metab Dispos 31:983–5
- Ji L, Yuan YL, Luo LP, et al. (2012). Physalins with anti-inflammatory activity are present in Physalis alkekengi var. franchetii and can function as Michael reaction acceptors. Steroids 77:441–7
- Kawai M, Ogura T, Makino B, et al. (1992). Physalins N and O from Physalis alkekengi. Phytochemistry 31:4299–302
- Kawai M, Makino B, Taga T, et al. (1994). Crystal structures of 5α,6α-epoxy and 2,3-dihydro derivatives of physalin B, a 13,14-seco-16,24-cyclosteroid, and their 1H NMR spectral analysis. Bull Chem Soc Jpn 67:222–6
- Lin Z, Guo Y, Gao Y, et al. (2015). ent-Kaurane diterpenoids from Chinese liverworts and their antitumor activities through Michael addition as detected in situ by a fluorescence probe. J Med Chem 58:3944–56
- Qiu L, Zhao F, Jiang ZH, et al. (2008). Steroids and flavonoids from Physalis alkekengi var. franchetii and their inhibitory effects on nitric oxide production. J Nat Prod 71:642–6
- Shu Z, Xing N, Wang Q, et al. (2016). Antibacterial and anti-Inflammatory activities of Physalis alkekengi var. franchetii and its main constituents. Evid Based Complement Alternat Med 2016:4359394
- Taga T, Miwa Y, Machida K, et al. (1991). Structure of 4,7-didehydroneophysalin B, acid-induced rearrangement product of physalin A. Acta Cryst C 47:2188–91
- Wikberg T, Taskinen T. (1993). Identification of major metabolites of the catechol-omethyltransferase inhibitor nitecapone in the rat and dog. Drug Metab Dispos 21:325–33
- Yoshino H, Matsunaga H, Kaneko H, et al. (1993). Metabolism of N-[4-chloro-2-fluoro-5-[(1-methyl-2-propynl)oxy]phenyl]-3,4,5, 6-tetrahydrophthalimide (S-23121) in the rat: I. Identification of a new, sulphonic acid type of conjugate. Xenobiotica 23:609–19
- Yang Y, Xie S, Xua W, et al. (2016). Six new physalins from Physalis alkekengi var. franchetii and their cytotoxicity and antibacterial activity. Fitoterapia 112:144–52
- Zhang JY, Yuan JJ, Wang YF, et al. (2003). Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice. Drug Metab Dispos 31:491–501
- Zhu FF, Dai CY, Fu YF, et al. (2016). Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling. Onco Target 7:9462–76